Skip to content

Released Nov 9, 2021, after the close

10-Q filed Nov 9, 2021, 40 days after period end · 0001636422-21-000077

Q3 2021 · 10-Q
Revenue$61.74M+30.8% vs Q3 2020+3.5% vs Q2 2021
Net Income-$40.01MN/M vs Q3 2020N/M vs Q2 2021
EPS Diluted-$0.82N/M vs Q3 2020N/M vs Q2 2021
Operating Income-$42,249,000N/M
Operating Cash Flowderived-$5,360,000N/M
Free Cash Flowderived-$7,049,000N/M
Margins · derived
Operating margin-68.4%−18.7 pt vs Q3 2020
Net margin-64.8%−6.9 pt vs Q3 2020

What the release said

The release

Same quarter

MetricQ3 2021Q3 2020Q3 2019Q3 2018
Revenue$61.74M$47.19M$39.42M$32.87M
Net Income-$40.01M-$27.33M-$21.42M-$16.88M
EPS Diluted-$0.82-$0.68-$1.40-$3.71

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR